Table 1. Sociodemographic and medical information of patients participated in the study of adverse drug effects of standard triple therapy in selected healthcare institutions at Bahir Dar City Administration, May 2016 to April 2018.
Variable and their categories | Frequency and percentage | Self-report on ADEs | Self-reported ADEs in % | |
---|---|---|---|---|
Yes (n = 110) | No (n = 311) | |||
Sex | ||||
Female | 276(65.6) | 80 | 196 | 29.0 |
Male | 145(34.4) | 30 | 115 | 20.7 |
Body mass index | ||||
<20 | 151(35.9) | 35 | 116 | 23.2 |
20–25 | 222(52.7) | 56 | 166 | 25.2 |
>25 | 48(11.4) | 19 | 29 | 39.6 |
Age in years | ||||
18–24 | 125(29.7) | 33 | 92 | 26.4 |
25–34 | 172(40.9) | 40 | 132 | 23.3 |
35–44 | 75(17.8) | 23 | 52 | 30.7 |
≥ 45 | 49(11.6) | 14 | 35 | 28.6 |
Residence | ||||
Urban | 336(79.8) | 95 | 241 | 28.3 |
Rural | 85(20.2) | 15 | 70 | 17.5 |
Patents' Zonal address | ||||
Bahir Dar city | 169(40.1) | 45 | 124 | 26.6 |
West Gojjam | 96(22.8) | 22 | 74 | 22.9 |
South Gondar | 62(14.7) | 15 | 47 | 24.2 |
Awi zone | 52(12.4) | 16 | 36 | 30.1 |
Others zones | 42(10.0) | 12 | 30 | 28.6 |
Marital status | ||||
Single | 145(34.5) | 34 | 111 | 23.4 |
Married | 267(63.4) | 73 | 194 | 27.3 |
Divorced/Widowed | 9(2.1) | 3 | 6 | 33.3 |
Occupation | ||||
Employee | 159 (37.8) | 46 | 113 | 28.9 |
Non-employee | 262(62.2) | 64 | 198 | 24.4 |
Educational status | ||||
Grade 1–8 and below | 141(33.5) | 35 | 106 | 24.8 |
Grade 9–12 | 104(24.7) | 30 | 74 | 28.8 |
College and above | 176(41.8) | 45 | 131 | 25.6 |
Time duration of the disorder | ||||
≤ 3weeks | 110(15.9) | 9 | 101 | 8.2 |
>3weeks | 354(84.1) | 101 | 253 | 28.5 |
Presence of other disease(s) | ||||
Yes | 108(25.6) | 25 | 83 | 23.1 |
No | 313(74.3) | 85 | 228 | 27.2 |
Self-reported alcohol intake | ||||
Yes | 237(56.3) | 52 | 185 | 21.9 |
No | 184(43.7) | 58 | 126 | 31.5 |
Pain feeling period in the day | ||||
After meal | 217(51.5) | 46 | 171 | 21.2 |
Persistent in the day | 122(29.0) | 35 | 87 | 28.7 |
Long interval b/n meals | 82(19.5) | 29 | 53 | 35.4 |
Use of Flaxseed or Fenugreek | ||||
Yes | 135(32.1) | 35 | 100 | 25.9 |
No | 286(67.9) | 75 | 211 | 26.2 |
Triple therapy regimen durations | ||||
10 day | 279(66.3) | 79 | 200 | 28.3 |
14 day | 142(33.7) | 31 | 111 | 21.8 |
Self-reported regimen completion | ||||
Yes | 397(94.3) | 100 | 297 | 25.2 |
No | 24(5.7) | 10 | 14 | 41.7 |
Disease symptom resolution | ||||
Yes | 355(84.3) | 91 | 264 | 25.6 |
No | 66(15.7) | 19 | 47 | 28.8 |